, small for gestational age, or neonatal death) between dolutegravir-based regimens and the other contemporary regimens.
Dolutegravir, a more recently approved antiretroviral drug, is part of a once-a-day regimen that has been shown to be more effective, easier to tolerate, and less likely to create new drug resistance in people with HIV-1 compared with other. However, limited data have been available about its effectiveness and safety in pregnancy compared with regimens that commonly have been used during pregnancy in the U.S. and Europe.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: wallpapermag - 🏆 36. / 67 Read more »
Source: wallpapermag - 🏆 36. / 67 Read more »
Source: AnOtherMagazine - 🏆 97. / 51 Read more »
Source: MotherAndBaby - 🏆 128. / 51 Read more »
Source: roadcc - 🏆 21. / 71 Read more »
In-Hospital Mortality Among Pregnant and Postpartum Individuals by Pregnancy PeriodThis cross-sectional study investigates trends in death rates and proportion of deaths by pregnancy period among pregnant and postpartum individuals from 1994 to 2019.
Source: medical_xpress - 🏆 101. / 51 Read more »